NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Abroad (travel likely)RecruitingPHASE1

Conditions

Depressive Disorder, Major · Depressive Disorder, Treatment-Resistant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Britt Gott, MS) · gottb@wustl.edu · 314-362-2463
Contact: Principal Investigator (Charles R Conway, MD)

Study leads

Charles R Conway, MD
Principal Investigator
Washington University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

M3VAS Validation in Polish Population

Depressive Disorder

Abroad (travel likely)Recruiting

Gdansk, Poland

Dosing rTMS for Depression Post-SCI

Spinal Cord Injuries · Depression · Depressive Disorder, Major

Abroad (travel likely)Recruiting

Charleston, United States

Optimal Electrical Stimulus During Electroconvulsive Therapy

Depressive Disorder, Major · Depression, Bipolar

Abroad (travel likely)RecruitingPHASE4

Örebro, Sweden

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Major Depressive Disorder (MDD)

Abroad (travel likely)RecruitingPHASE2

Garden Grove, United States